Trials / Not Yet Recruiting
Not Yet RecruitingNCT06767163
Developing a Daily-use Fall Risk Assessment Device in Clinical Setting
Development and Applications of Daily-use Fall Risk Assessment Device to Prevent Elderly People from Falling
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- The University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 60 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
Study Objectives Objective 1: Compare the fall risk assessment results between balance sensors, traditional tests, and clinical diagnoses. Objective 2: Improve the feasibility of using sensors to assess fall risk among older patients in the hospital. The investigators select Hong Kong as the region for the experiment. Specifically, the community clinics and daytime hospitals are the actual onsite locations for experimenting. The specific venues of these locations need an electrical power supply and a flat ground for conducting the device test. Patients will be recruited for the development and testing of a device for fall risk assessment, study participants will be involved in balancing assessments, and questionnaire surveys, their medical records will be accessed. And during these tests and questionnaire surveys, the investigators will take photos, videos, and or audio recordings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iBalance | Participants will engage in the device test, clinical assessment tests. The whole test will last twelve months, and the outcome will be assessed pre- and post-implementation for comparison and validation. The intervention results are used to compared with traditional tests and clinical diagnosis, to identify whether the sensor provides a higher accuracy in predicting fall risk, and to explore the feasibility of the sensor in clinical scenarios. |
Timeline
- Start date
- 2025-02-01
- Primary completion
- 2025-12-31
- Completion
- 2026-02-01
- First posted
- 2025-01-09
- Last updated
- 2025-01-20
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT06767163. Inclusion in this directory is not an endorsement.